Human application of ex vivo expanded umbilical cord-derived mesenchymal stem cells: Enhance hematopoiesis after cord blood transplantation

Cell Transplantation

Volumn 22, Issue 11, 2013, Pages 2041-2051

  Wu, Kang Hsi ^a,b   Tsai, Chris ^c   Wu, Han Ping ^d   Sieber, Martin ^c   Peng, Ching Tien ^b,e   Chao, Yu Hua ^f,g  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c Bionet Corp   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cord blood transplantation (CBT); Mesenchymal stem cells (MSCs); Umbilical cord

Indexed keywords

ACICLOVIR; BUSULFAN; CD45 ANTIGEN; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIGEN PP65; ETOPOSIDE; GANCICLOVIR; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY; VORICONAZOLE; BIOLOGICAL MARKER;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BANK; CELL ISOLATION; CELL PROLIFERATION; CEREBROSPINAL FLUID; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; ENGRAFTMENT; EX VIVO STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOPROPHYLAXIS; INVASIVE PROCEDURE; LEUKEMIA; LEUKEMIA REMISSION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; MYELODYSPLASTIC SYNDROME; NOD SCID MOUSE; NONHUMAN; PHILADELPHIA 1 CHROMOSOME; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; WHARTON JELLY; ANIMAL; BONE MARROW CELL; CYTOLOGY; LEUKEMIA, MYELOID, ACUTE; MESENCHYMAL STROMA CELL; METABOLISM; MORTALITY; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SCID MOUSE; SURVIVAL RATE; TREATMENT OUTCOME;

MUS;

ADOLESCENT; ANIMALS; BIOLOGICAL MARKERS; BONE MARROW CELLS; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HEMATOPOIESIS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; SURVIVAL RATE; TREATMENT OUTCOME; WHARTON JELLY;

EID: 84886399742     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X663533     Document Type: Article

References (35)

1. Amariglio, N.; Hirshberg, A.; Scheithauer, B. W.; Cohen, Y.; Loewenthal, R.; Trakhtenbrot, L.; Paz, N.; Koren-Michowitz, M.; Waldman, D.; Leider-Trejo, L.; Toren, A.; Constantini, S.; Rechavi, G. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 6:221-231; 2009.
2. Antonucci, I.; Stuppia, L.; Kaneko, Y.; Yu, S.; Tajiri, N.; Bae, E. C.; Chheda, S. H.; Weinbren, N. L.; Borlongan, C. V. Amniotic fluid as a rich source of mesenchymal stromal cells for transplantation therapy. Cell Transplant. 20:789-795; 2011.
3. Baksh, D.; Yao, R.; Tuan, R. S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived umbilical cord and bone marrow. Stem Cells 25:1384-1392; 2007.
4. Ball, L. M.; Bernardo, M. E.; Roelofs, H.; Lankester, A.; Cometa, A.; Egeler, R. M.; Locatelli, F.; Fibbe, W. E. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem cell transplantation. Blood 110:2764-2767; 2007.
5. Chang, J. W.; Hung, S. P.; Wu, H. H.; Wu, W. M.; Yang, A. H.; Tsai, H. L.; Yang, L. Y.; Lee, O. K. Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Cell Transplant. 20:245-257; 2011.
6. Chao, Y. H.; Peng, C. T.; Harn, H. J.; Chan, C. K.; Wu, K. H. Poor potential of proliferation and differentiation in bone marrow mesenchymal stem cells derived from children with severe aplastic anemia. Ann. Hematol. 89:715-723; 2010.
7. Chao, Y. H.; Tsai, C.; Peng, C. T.; Wu, H. P.; Chan, C. K.; Weng, T.; Wu, K. H. Cotransplantation of umbilical cord MSCs to enhance engraftment of hematopoietic stem cells in patients with severe aplastic anemia. Bone Marrow Transplant. 46:1391-1392; 2011.
8. Deuse, T.; Stubbendorff, M.; Tang-Quan, K.; Phillips, N.; Kay, M. A.; Eiermann, T.; Phan, T. T.; Volk, H. D.; Reichenspurner, H.; Robbins, R. C.; Schrepfer, S. Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant. 20:655-667; 2011.
9. Ding, D. C.; Shyu, W. C.; Lin, S. Z. Mesenchymal stem cells. Cell Transplant. 20:5-14; 2011.
10. Galotto, M.; Berisso, G.; Delfino, L.; Podesta, M.; Ottaggio, L.; Dallorso, S.; Dufour, C.; Ferrara, G. B.; Abbondandolo, A.; Dini, G.; Bacigalupo, A.; Cancedda, R.; Quarto, R. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp. Hematol. 27:1460-1466; 1999.
11. Gluckman, E. History of cord blood transplantation. Bone Marrow Transplant. 44:621-626; 2009.
12. Gong, W.; Han, Z.; Zhao, H.; Wang, Y.; Wang, J.; Zhong, J.; Wang, B.; Wang, S.; Wang, Y.; Sun, L.; Han, Z. Banking human umbilical cord derived mesenchymal stromal cells for clinical use. Cell Transplant. 21:207-216; 2012.
13. Hunt, D. P.; Irvine, K. A.; Webber, D. J.; Compston, D. A.; Blakemore, W. F.; Chandran, S. Effects of direct transplantation of multipotent mesenchymal stromal/stem cells into the demyelinated spinal cord. Cell Transplant. 17:865-873; 2008.
14. Iop, L.; Chiavegato, A.; Callegari, A.; Bollini, S.; Piccoli, M.; Pozzobon, M.; Rossi, C. A.; Calamelli, S.; Chiavegato, D.; Gerosa, G.; De Coppi, P.; Sartore, S. Different cardiovascular potential of adult- and fetal-type mesenchymal stem cells in a rat model of heart cryoinjury. Cell Transplant. 17:679-694; 2008.
15. Keyser, K. A.; Beagles, K. E.; Kiem, H. P. Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation. Cell Transplant. 16:555-562; 2007.
16. Koç, O. N.; Gerson, S. L.; Cooper, B. W.; Dyhouse, S. M.; Haynesworth, S. E.; Caplan, A. I.; Lazarus, H. M. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J. Clin. Oncol. 18:307-316; 2000.
17. Koldehoff, M.; Steckel, N. K.; Hlinka, M.; Beelen, D. W.; Elmaagacli, A. H. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences. Am. J. Hematol. 81:735-746; 2006.
18. Lazarus, H. M.; Koc, O. N.; Devine, S. M.; Curtin, P.; Maziarz, R. T.; Holland, H. K.; Shpall, E. J.; McCarthy, P.; Atkinson, K.; Cooper, B. W.; Gerson, S. L.; Laughlin, M. J.; Loberiza, F. R.; Moseley, Jr., A. B.; Bacigalupo, A. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol. Blood Marrow Transplant. 11:389-398; 2005.
19. Le Blanc, K.; Frassoni, F.; Ball, L.; Locatelli, F.; Roelofs, H.; Lewis, I.; Lanino, E.; Sundberg, B.; Bernardo, M. E.; Remberger, M.; Dini, G.; Egeler, R. M.; Bacigalupo, A.; Fibbe, W.; Ringdén, O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371:1579-1586; 2008.
20. Le Blanc, K.; Rasmusson, I.; Sundberg, B.; Götherström, C.; Hassan, M.; Uzunel, M.; Ringdén, O. Treatment of severe acute graft-versus-host disease with third-party haploidentical mesenchymal stem cells. Lancet 363:1439-1441; 2004.
21. Le Blanc, K.; Samuelsson, H.; Gustafsson, B.; Remberger, M.; Sundberg, B.; Arvidson, J.; Ljungman, P.; Lönnies, H.; Nava, S.; Ringdén, O. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 21:1733-1738; 2007.
22. Macmillan, M. L.; Blazar, B. R.; DeFor, T. E.; Wagner, J. E. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: Results of a phase I-II clinical trial. Bone Marrow Transplant. 43:447-454; 2009.
23. Magatti, M.; De Munari, S.; Vertua, E.; Nassauto, C.; Albertini, A.; Wengler, G. S.; Parolini, O. Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant. 18:899-914; 2009.
24. Marchetti, S.; Santangelo, R.; Manzara, S.; D'Onghia, S.; Fadda, G.; Cattani, P. Comparison of real-time PCR and pp 65 antigen assays for monitoring the development of Cytomegalovirus disease in recipients of solid organ and bone marrow transplants. New Microbiol. 34:157-164; 2011.
25. Nauta, A. J.; Fibbe, W. E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506; 2007.
26. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147; 1999.
27. Poloni, A.; Leoni, P.; Buscemi, L.; Balducci, F.; Pasquini, R.; Masia, M. C.; Viola, N.; Costantino, E.; Discepoli, G.; Corradini, P.; Tagliabracci, A.; Olivieri, A. Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen. Leukemia 20:329-335; 2006.
28. Querol, S.; Rubinstein, P.; Marsh, S. G.; Goldman, J.; Madrigal, J. A. Cord blood banking: "Providing cord blood banking for a nation." Br. J. Haematol. 147:227-235; 2009.
29. Ringdén, O.; Uzunel, M.; Rasmusson, I.; Remberger, M.; Sundberg, B.; Lönnies, H.; Marschall, H. U.; Dlugosz, A.; Szakos, A.; Hassan, Z.; Omazic, B.; Aschan, J.; Barkholt, L.; Le Blanc, K. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81:1390-1397; 2006.
30. Rubinstein, P.; Carrier, C.; Scaradavou, A.; Kurtzberg, J.; Adamson, J.; Migliaccio, A. R.; Berkowitz, R. L.; Cabbad, M.; Dobrila, N. L.; Taylor, P. E.; Rosenfield, R. E.; Stevens, C. E. Outcomes among 562 recipients of placental- blood transplants from unrelated donors. N. Engl. J. Med. 339:1565-1577; 1998.
31. Sattler, C.; Steinsdoerfer, M.; Offers, M.; Fischer, E.; Schierl, R.; Heseler, K.; Däubener, W.; Seissler, J. Inhibition of T cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation. Cell Transplant. 20:1221-1230; 2011.
32. Secco, M.; Zucconi, E.; Vieira, N. M.; Fogaça, L. L.; Cerqueira, A.; Carvalho, M. D.; Jazedje, T.; Okamoto, O. K.; Muotri, A. R.; Zatz, M. Multipotent stem cells from umbilical cord: Cord is richer than blood! Stem Cells 26: 146-150; 2008.
33. Verfaillie, C. M. Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. Blood 79:2821-2826; 1992.
34. Wu, K. H.; Chan, C. K.; Tsai, C.; Chang, Y. H.; Sieber, M.; Chiu, T. H.; Ho, M.; Peng, C. T.; Wu, H. P.; Huang, J. L. Effective treatment of severe steroid-resistant acute graftversus- host disease with umbilical cord-derived mesenchymal stem cells. Transplantation 91:1412-1416; 2011.
35. Yagi, H.; Soto-Gutierrez, A.; Parekkadan, B.; Kitagawa, Y.; Tompkins, R. G.; Kobayashi, N.; Yarmush, M. L. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant. 19:667-679; 2010.